Results of Surgical Treatment of the Hepatobiliopancreatic Surgical Unit
NCT ID: NCT04556019
Last Updated: 2020-09-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1000 participants
OBSERVATIONAL
2019-01-03
2029-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. \- to evaluate post-surgical morbidity and mortality outcomes, following the criteria and the definitions from Claven-Dindo and ISGPS international classifications, of the patients operated by the HPB Surgical Unit.
2. \- to evaluate survival and disease-free survival rates of the patients operated by the HPB Surgical Unit due to tumoral cause.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pancreatoduodenectomy in Pancreatic and Periampullary Tumors
NCT02803814
Benchmarking Outcomes in Pancreatic Surgery - WhippleBenchmarks.Org
NCT04053998
Early POstoperative BIomarkers in PancreatoDuodenectomy: a Spanish Nationwide Study
NCT04342923
Influence of the Endoscopists and Endoscopic Retrograde CholangioPanceratography
NCT04705740
Value of the Laparoscopic Approach in the Surgical Management of Resectable Hepatocellular Carcinoma
NCT04791735
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hepatobiliopancreatic surgery
Different surgical techniques tailored to each patient´s pathology
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* All patients being operated by the HPB Surgical Unit from January 2019 onwards who provide inform consent (prospective).
Exclusion Criteria
* Patients not interested in taking part in the study
15 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fundacion Miguel Servet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Francisco Javier Herrera Cabezón, MD
Role: PRINCIPAL_INVESTIGATOR
Complejo Hospitalario de Navarra
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Complejo Hospitalario de Navarra
Pamplona, Navarre, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CIRUGIA HPB-CHN
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.